Regulation of ROS production by succubate dehydrogenase in cardiac ischemia reperfusion

Autores
Viteri Álvarez, Sonia Valeria
Año de publicación
2019
Idioma
inglés
Tipo de recurso
tesis de maestría
Estado
versión aceptada
Colaborador/a o director/a de tesis
Alvarez, Silvia
Bugger, Heiko
Donato, Martín
Mosca, Susana
Hannibal, Luciana
Descripción
Myocardial infarction is a worldwide public health problem with a very poor prognosis1. The use of thrombolytic therapy or percutaneous coronary intervention have demonstrated a high effectiveness in reducing lesion size after myocardial infarction. This beneficial effect is largely due to the limitation of myocardial ischemia. While ultimately limiting myocardial infarct size, restoration of blood flow also causes additional cardiac injury termed reperfusion injury 2. Both mechanisms of cardiac injury, i.e. ischemia and reperfusion, are summarized as ischemia-reperfusion (I/R) injury. Mechanisms proposed to contribute to I/R injury include impaired mitochondrial energetics, dysregulation of intracellular Ca2+ handling, rapid restoration of physiologic pH, inflammation, opening of the mitochondrial permeability transition pore (PTP), and reactive oxygen species (ROS) generation2.\nWhile ROS production during I/R is still incompletely understood, Chouchani et al.1 recently provided evidence for an important role of succinate-driven ROS generation. During ischemia, succinate seems to accumulate due to succinate dehydrogenase (SDH)-mediated reduction of fumarate to succinate. Upon reperfusion, SDH immediately oxidizes the accumulated succinate and, with complex III and IV at full capacity, drives reverse electron transport (RET) through mitochondrial complex I, resulting in superoxide formation which may even account for the major part of mitochondrial ROS generated during I/R1.\nRecent evidence implies a role for mitochondrial sirtuins in regulating mitochondrial ROS generation. Sirtuins (SIRTs) are NAD+-dependent deacylases that regulate target enzyme activity by removal of protein lysine modifications. Among a total of seven mammalian orthologs, sirtuin 5 (SIRT5) is primarily localized within mitochondria where it primarily modifies energy metabolic enzymes by desuccinylation, demalonylation and deglutarylation, including SDH.3 Recently, lack of SIRT5 in mice has been shown to impair the recovery of cardiac function following I/R, and it has been proposed that increased succinylation of SDH may lead to RET-mediated ROS production. Since this mechanism remains poorly elucidated, it is our superior objective to understand how SIRT5 regulates mitochondrial ROS production and I/R injury. Since such studies will\nrequire specific interventions such as mutation studies and pharmacological treatments in an appropriate model system, the specific aim of the current master thesis project was to establish a knockdown of SIRT5 in H9C2 cardiac myoblasts using RNA interference, as well as to establish an I/R protocol that may mimic the in vivo condition of I/R injury.
Fil: Viteri Álvarez, Sonia Valeria. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Buenos Aires, Argentina
Magíster de la Universidad de Buenos Aires en Ciencias Biomédicas
Materia
Isquemia cardiaca
Especies de óxigeno reactivo
Reactive oxygen species
ROS
SIRT5
Cardiac ischemia reperfusion
Ciencias de la vida
Nivel de accesibilidad
acceso abierto
Condiciones de uso
http://creativecommons.org/licenses/by-nc-nd/2.5/ar/
Repositorio
Repositorio Digital Institucional de la Universidad de Buenos Aires
Institución
Universidad de Buenos Aires
OAI Identificador
oai:RDI UBA:afamaster:HWA_5941

id RDIUBA_bcf83842b8e7c23b0a6ed24aa9ab0c49
oai_identifier_str oai:RDI UBA:afamaster:HWA_5941
network_acronym_str RDIUBA
repository_id_str
network_name_str Repositorio Digital Institucional de la Universidad de Buenos Aires
spelling Regulation of ROS production by succubate dehydrogenase in cardiac ischemia reperfusionViteri Álvarez, Sonia ValeriaIsquemia cardiacaEspecies de óxigeno reactivoReactive oxygen speciesROSSIRT5Cardiac ischemia reperfusionCiencias de la vidaMyocardial infarction is a worldwide public health problem with a very poor prognosis1. The use of thrombolytic therapy or percutaneous coronary intervention have demonstrated a high effectiveness in reducing lesion size after myocardial infarction. This beneficial effect is largely due to the limitation of myocardial ischemia. While ultimately limiting myocardial infarct size, restoration of blood flow also causes additional cardiac injury termed reperfusion injury 2. Both mechanisms of cardiac injury, i.e. ischemia and reperfusion, are summarized as ischemia-reperfusion (I/R) injury. Mechanisms proposed to contribute to I/R injury include impaired mitochondrial energetics, dysregulation of intracellular Ca2+ handling, rapid restoration of physiologic pH, inflammation, opening of the mitochondrial permeability transition pore (PTP), and reactive oxygen species (ROS) generation2.\nWhile ROS production during I/R is still incompletely understood, Chouchani et al.1 recently provided evidence for an important role of succinate-driven ROS generation. During ischemia, succinate seems to accumulate due to succinate dehydrogenase (SDH)-mediated reduction of fumarate to succinate. Upon reperfusion, SDH immediately oxidizes the accumulated succinate and, with complex III and IV at full capacity, drives reverse electron transport (RET) through mitochondrial complex I, resulting in superoxide formation which may even account for the major part of mitochondrial ROS generated during I/R1.\nRecent evidence implies a role for mitochondrial sirtuins in regulating mitochondrial ROS generation. Sirtuins (SIRTs) are NAD+-dependent deacylases that regulate target enzyme activity by removal of protein lysine modifications. Among a total of seven mammalian orthologs, sirtuin 5 (SIRT5) is primarily localized within mitochondria where it primarily modifies energy metabolic enzymes by desuccinylation, demalonylation and deglutarylation, including SDH.3 Recently, lack of SIRT5 in mice has been shown to impair the recovery of cardiac function following I/R, and it has been proposed that increased succinylation of SDH may lead to RET-mediated ROS production. Since this mechanism remains poorly elucidated, it is our superior objective to understand how SIRT5 regulates mitochondrial ROS production and I/R injury. Since such studies will\nrequire specific interventions such as mutation studies and pharmacological treatments in an appropriate model system, the specific aim of the current master thesis project was to establish a knockdown of SIRT5 in H9C2 cardiac myoblasts using RNA interference, as well as to establish an I/R protocol that may mimic the in vivo condition of I/R injury.Fil: Viteri Álvarez, Sonia Valeria. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Buenos Aires, ArgentinaMagíster de la Universidad de Buenos Aires en Ciencias BiomédicasUniversidad de Buenos Aires. Facultad de Farmacia y BioquímicaAlvarez, SilviaBugger, HeikoDonato, MartínMosca, SusanaHannibal, Luciana2019-03-26info:eu-repo/semantics/masterThesisinfo:eu-repo/semantics/acceptedVersionhttp://purl.org/coar/resource_type/c_bdccinfo:ar-repo/semantics/tesisDeMaestriaapplication/pdfhttp://repositoriouba.sisbi.uba.ar/gsdl/cgi-bin/library.cgi?a=d&c=afamaster&cl=CL1&d=HWA_5941https://repositoriouba.sisbi.uba.ar/gsdl/collect/afamaster/index/assoc/HWA_5941.dir/5941.PDFenginfo:eu-repo/semantics/openAccesshttp://creativecommons.org/licenses/by-nc-nd/2.5/ar/reponame:Repositorio Digital Institucional de la Universidad de Buenos Airesinstname:Universidad de Buenos Aires2025-09-29T15:13:07Zoai:RDI UBA:afamaster:HWA_5941instacron:UBAInstitucionalhttp://repositoriouba.sisbi.uba.ar/Universidad públicahttps://www.uba.ar/http://repositoriouba.sisbi.uba.ar/gsdl/cgi-bin/oaiserver.cgicferrando@sisbi.uba.arArgentinaopendoar:2025-09-29 15:13:07.739Repositorio Digital Institucional de la Universidad de Buenos Aires - Universidad de Buenos Airesfalse
dc.title.none.fl_str_mv Regulation of ROS production by succubate dehydrogenase in cardiac ischemia reperfusion
title Regulation of ROS production by succubate dehydrogenase in cardiac ischemia reperfusion
spellingShingle Regulation of ROS production by succubate dehydrogenase in cardiac ischemia reperfusion
Viteri Álvarez, Sonia Valeria
Isquemia cardiaca
Especies de óxigeno reactivo
Reactive oxygen species
ROS
SIRT5
Cardiac ischemia reperfusion
Ciencias de la vida
title_short Regulation of ROS production by succubate dehydrogenase in cardiac ischemia reperfusion
title_full Regulation of ROS production by succubate dehydrogenase in cardiac ischemia reperfusion
title_fullStr Regulation of ROS production by succubate dehydrogenase in cardiac ischemia reperfusion
title_full_unstemmed Regulation of ROS production by succubate dehydrogenase in cardiac ischemia reperfusion
title_sort Regulation of ROS production by succubate dehydrogenase in cardiac ischemia reperfusion
dc.creator.none.fl_str_mv Viteri Álvarez, Sonia Valeria
author Viteri Álvarez, Sonia Valeria
author_facet Viteri Álvarez, Sonia Valeria
author_role author
dc.contributor.none.fl_str_mv Alvarez, Silvia
Bugger, Heiko
Donato, Martín
Mosca, Susana
Hannibal, Luciana
dc.subject.none.fl_str_mv Isquemia cardiaca
Especies de óxigeno reactivo
Reactive oxygen species
ROS
SIRT5
Cardiac ischemia reperfusion
Ciencias de la vida
topic Isquemia cardiaca
Especies de óxigeno reactivo
Reactive oxygen species
ROS
SIRT5
Cardiac ischemia reperfusion
Ciencias de la vida
dc.description.none.fl_txt_mv Myocardial infarction is a worldwide public health problem with a very poor prognosis1. The use of thrombolytic therapy or percutaneous coronary intervention have demonstrated a high effectiveness in reducing lesion size after myocardial infarction. This beneficial effect is largely due to the limitation of myocardial ischemia. While ultimately limiting myocardial infarct size, restoration of blood flow also causes additional cardiac injury termed reperfusion injury 2. Both mechanisms of cardiac injury, i.e. ischemia and reperfusion, are summarized as ischemia-reperfusion (I/R) injury. Mechanisms proposed to contribute to I/R injury include impaired mitochondrial energetics, dysregulation of intracellular Ca2+ handling, rapid restoration of physiologic pH, inflammation, opening of the mitochondrial permeability transition pore (PTP), and reactive oxygen species (ROS) generation2.\nWhile ROS production during I/R is still incompletely understood, Chouchani et al.1 recently provided evidence for an important role of succinate-driven ROS generation. During ischemia, succinate seems to accumulate due to succinate dehydrogenase (SDH)-mediated reduction of fumarate to succinate. Upon reperfusion, SDH immediately oxidizes the accumulated succinate and, with complex III and IV at full capacity, drives reverse electron transport (RET) through mitochondrial complex I, resulting in superoxide formation which may even account for the major part of mitochondrial ROS generated during I/R1.\nRecent evidence implies a role for mitochondrial sirtuins in regulating mitochondrial ROS generation. Sirtuins (SIRTs) are NAD+-dependent deacylases that regulate target enzyme activity by removal of protein lysine modifications. Among a total of seven mammalian orthologs, sirtuin 5 (SIRT5) is primarily localized within mitochondria where it primarily modifies energy metabolic enzymes by desuccinylation, demalonylation and deglutarylation, including SDH.3 Recently, lack of SIRT5 in mice has been shown to impair the recovery of cardiac function following I/R, and it has been proposed that increased succinylation of SDH may lead to RET-mediated ROS production. Since this mechanism remains poorly elucidated, it is our superior objective to understand how SIRT5 regulates mitochondrial ROS production and I/R injury. Since such studies will\nrequire specific interventions such as mutation studies and pharmacological treatments in an appropriate model system, the specific aim of the current master thesis project was to establish a knockdown of SIRT5 in H9C2 cardiac myoblasts using RNA interference, as well as to establish an I/R protocol that may mimic the in vivo condition of I/R injury.
Fil: Viteri Álvarez, Sonia Valeria. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Buenos Aires, Argentina
Magíster de la Universidad de Buenos Aires en Ciencias Biomédicas
description Myocardial infarction is a worldwide public health problem with a very poor prognosis1. The use of thrombolytic therapy or percutaneous coronary intervention have demonstrated a high effectiveness in reducing lesion size after myocardial infarction. This beneficial effect is largely due to the limitation of myocardial ischemia. While ultimately limiting myocardial infarct size, restoration of blood flow also causes additional cardiac injury termed reperfusion injury 2. Both mechanisms of cardiac injury, i.e. ischemia and reperfusion, are summarized as ischemia-reperfusion (I/R) injury. Mechanisms proposed to contribute to I/R injury include impaired mitochondrial energetics, dysregulation of intracellular Ca2+ handling, rapid restoration of physiologic pH, inflammation, opening of the mitochondrial permeability transition pore (PTP), and reactive oxygen species (ROS) generation2.\nWhile ROS production during I/R is still incompletely understood, Chouchani et al.1 recently provided evidence for an important role of succinate-driven ROS generation. During ischemia, succinate seems to accumulate due to succinate dehydrogenase (SDH)-mediated reduction of fumarate to succinate. Upon reperfusion, SDH immediately oxidizes the accumulated succinate and, with complex III and IV at full capacity, drives reverse electron transport (RET) through mitochondrial complex I, resulting in superoxide formation which may even account for the major part of mitochondrial ROS generated during I/R1.\nRecent evidence implies a role for mitochondrial sirtuins in regulating mitochondrial ROS generation. Sirtuins (SIRTs) are NAD+-dependent deacylases that regulate target enzyme activity by removal of protein lysine modifications. Among a total of seven mammalian orthologs, sirtuin 5 (SIRT5) is primarily localized within mitochondria where it primarily modifies energy metabolic enzymes by desuccinylation, demalonylation and deglutarylation, including SDH.3 Recently, lack of SIRT5 in mice has been shown to impair the recovery of cardiac function following I/R, and it has been proposed that increased succinylation of SDH may lead to RET-mediated ROS production. Since this mechanism remains poorly elucidated, it is our superior objective to understand how SIRT5 regulates mitochondrial ROS production and I/R injury. Since such studies will\nrequire specific interventions such as mutation studies and pharmacological treatments in an appropriate model system, the specific aim of the current master thesis project was to establish a knockdown of SIRT5 in H9C2 cardiac myoblasts using RNA interference, as well as to establish an I/R protocol that may mimic the in vivo condition of I/R injury.
publishDate 2019
dc.date.none.fl_str_mv 2019-03-26
dc.type.none.fl_str_mv info:eu-repo/semantics/masterThesis
info:eu-repo/semantics/acceptedVersion
http://purl.org/coar/resource_type/c_bdcc
info:ar-repo/semantics/tesisDeMaestria
format masterThesis
status_str acceptedVersion
dc.identifier.none.fl_str_mv http://repositoriouba.sisbi.uba.ar/gsdl/cgi-bin/library.cgi?a=d&c=afamaster&cl=CL1&d=HWA_5941
https://repositoriouba.sisbi.uba.ar/gsdl/collect/afamaster/index/assoc/HWA_5941.dir/5941.PDF
url http://repositoriouba.sisbi.uba.ar/gsdl/cgi-bin/library.cgi?a=d&c=afamaster&cl=CL1&d=HWA_5941
https://repositoriouba.sisbi.uba.ar/gsdl/collect/afamaster/index/assoc/HWA_5941.dir/5941.PDF
dc.language.none.fl_str_mv eng
language eng
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
http://creativecommons.org/licenses/by-nc-nd/2.5/ar/
eu_rights_str_mv openAccess
rights_invalid_str_mv http://creativecommons.org/licenses/by-nc-nd/2.5/ar/
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica
publisher.none.fl_str_mv Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica
dc.source.none.fl_str_mv reponame:Repositorio Digital Institucional de la Universidad de Buenos Aires
instname:Universidad de Buenos Aires
reponame_str Repositorio Digital Institucional de la Universidad de Buenos Aires
collection Repositorio Digital Institucional de la Universidad de Buenos Aires
instname_str Universidad de Buenos Aires
repository.name.fl_str_mv Repositorio Digital Institucional de la Universidad de Buenos Aires - Universidad de Buenos Aires
repository.mail.fl_str_mv cferrando@sisbi.uba.ar
_version_ 1844624351826018304
score 12.559606